[READ MORE: Realistic Bleeding Control Training Goes Global](https://lunalabs.us/bleeding-control-medica/)
[READ MORE: Realistic Bleeding Control Training Goes Global](https://lunalabs.us/bleeding-control-medica/)
powered by bulletin
This funding will be critical as we continue to expand our joint reduction trainer product line. We design our trainers to teach students proper hand and body positioning for both the patient and the clinician. Students gain the complete realistic experience of treating a patient from injury assessment through complete reduction, building the skills and confidence needed to perform in emergency situations.
Kelley Virgilio head shot
Kelly Virgilio, PhD
Lead PI for Luna Labs' joint reduction program

The Virginia Innovation Partnership Corporation (VIPC) Commonwealth Commercialization Fund (CCF) awarded $75,000 to Luna Labs’ medical simulation program to expand our line of joint reduction trainers (previously known as JRT, now Dislotech). Finger trainers will soon join Luna Labs’ TrueClot® bleeding control trainers and Dislotech Shoulder Joint Reduction Trainer in our expanding portfolio of medical simulation technologies. 

With the official launch of our shoulder reduction trainer in June at the National Athletic Trainers’ Association Expo, medical personnel now have ready access to repeated hands-on training to master shoulder reduction rather than limited trial and error on live patients or training with low-fidelity trainers. 

With a very limited number of joint reduction training tools on the market, many medical professionals currently get their training from videos with no actual experience until executing the technique on an injured patient for the first time. Dislotech provides hands-on opportunities to practice reducing a joint using anatomically correct features. 

The Luna Labs' Dislotech Shoulder Joint Reduction Trianer
Luna Lab's Dislotech shoulder reduction trainer
Prototype of Dislotech's finger reduction trainer.
Prototype of Dislotech's finger reduction trainer

The VIPC CCF funds come at a particularly important time. Organizations seeking Commission on Accreditation of Athletic Training Education (CAATE) accreditation must now comply with Standard 70 which sets out guidelines for evaluating and managing patients with acute, life threatening, or emergent conditions including dislocations. Athletic training programs seeking CAATE accreditation must show these standards are addressed through clinical education experiences and assessment tools. Emergency Medical Technicians (EMTs) have also begun to include joint reductions in their scope of practice. 

Standard 70 also addresses internal and external hemorrhage (including use of a tourniquet and hemostatic agents), the domain of our TrueClot® bleeding control, wound packing, and tourniquet trainers.  

Luna Labs has been manufacturing TrueClot in Virginia since 2013. We are excited to add the Dislotech line of trainers to our portfolio of medical simulation products. The CCF funds will accelerate commercialization of Dislotech and ultimately provide enhanced skills development for athletic trainers and healthcare professionals.
Michael Danilich, PhD
Sr. VP of Operations, Luna Labs

The VIPC is the non-profit arm of the Virginia Innovation Partnership Authority (VIPA) tasked with supporting Virginia’s innovators and entrepreneurs. The CCF is the mechanism through which the VIPC supports commercialization efforts and stimulates economic development.

Read the VIPC CCF press release. VIPC Awards Commonwealth Commercialization Fund Grant to Luna Labs For Expansion Of Medical Simulation Product Line – World News Report – EIN Presswire (einnews.com) 

Categories


Newsletter Signup

Get the latest news from Luna Labs' biotech, materials, systems, and medical simulation teams.